ADA and severe combined immunodeficiency: EFS-ADA is a 4-kb LV for treating ADA severe combined immunodeficiency (ADA-SCID) that is capable of high-level and consistent ADA gene transfer and expression (Carbonaro et al., 2014; Schambach et al., 2006).